Healthcare Services (HCSG)
Market Price (4/30/2026): $21.32 | Market Cap: $1.5 BilSector: Industrials | Industry: Environmental & Facilities Services
Healthcare Services (HCSG)
Market Price (4/30/2026): $21.32Market Cap: $1.5 BilSector: IndustrialsIndustry: Environmental & Facilities Services
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -11% Attractive yieldFCF Yield is 10% Low stock price volatilityVol 12M is 44% Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care. | Weak multi-year price returns3Y Excs Rtn is -23% | Key risksHCSG key risks include [1] substantial legal liability and reputational damage stemming from a recent data breach that compromised the personal and medical details of over 624,000 individuals. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -11% |
| Attractive yieldFCF Yield is 10% |
| Low stock price volatilityVol 12M is 44% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care. |
| Weak multi-year price returns3Y Excs Rtn is -23% |
| Key risksHCSG key risks include [1] substantial legal liability and reputational damage stemming from a recent data breach that compromised the personal and medical details of over 624,000 individuals. |
Qualitative Assessment
AI Analysis | Feedback
1. Strong Earnings Performance and Profitability Improvement.
Healthcare Services Group significantly surpassed earnings per share (EPS) estimates for both Q4 2025 and Q1 2026. For Q4 2025, reported in February 2026, the company posted an EPS of $0.44, beating analyst expectations of $0.23 by 91.30%. Similarly, for Q1 2026, reported in April 2026, EPS was $0.37, exceeding estimates of $0.21 by $0.16, marking a 68.18% surprise. This strong bottom-line performance was driven by operational excellence, resulting in a nearly 51% year-over-year surge in Q1 2026 net income to $26.06 million and an improved adjusted EBITDA margin of 8.4% compared to 6.5% in the prior-year quarter. The company also maintained its cost of services at 83.6% of revenue, below its 86% target.
2. Accelerated Share Repurchase Program.
In February 2026, Healthcare Services Group announced an accelerated plan to repurchase $75.0 million of its common stock through January 2027. Demonstrating this commitment to returning capital to shareholders, the company repurchased $24.0 million of its common stock during the first quarter of 2026.
Show more
Stock Movement Drivers
Fundamental Drivers
The 11.6% change in HCSG stock from 12/31/2025 to 4/29/2026 was primarily driven by a 66.8% change in the company's Net Income Margin (%).| (LTM values as of) | 12312025 | 4292026 | Change |
|---|---|---|---|
| Stock Price ($) | 19.12 | 21.33 | 11.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,808 | 1,852 | 2.4% |
| Net Income Margin (%) | 2.2% | 3.7% | 66.8% |
| P/E Multiple | 34.8 | 21.9 | -36.9% |
| Shares Outstanding (Mil) | 72 | 70 | 3.4% |
| Cumulative Contribution | 11.6% |
Market Drivers
12/31/2025 to 4/29/2026| Return | Correlation | |
|---|---|---|
| HCSG | 11.6% | |
| Market (SPY) | 5.2% | 28.5% |
| Sector (XLI) | 9.9% | 11.8% |
Fundamental Drivers
The 26.7% change in HCSG stock from 9/30/2025 to 4/29/2026 was primarily driven by a 500.7% change in the company's Net Income Margin (%).| (LTM values as of) | 9302025 | 4292026 | Change |
|---|---|---|---|
| Stock Price ($) | 16.83 | 21.33 | 26.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,772 | 1,852 | 4.5% |
| Net Income Margin (%) | 0.6% | 3.7% | 500.7% |
| P/E Multiple | 113.9 | 21.9 | -80.7% |
| Shares Outstanding (Mil) | 73 | 70 | 4.7% |
| Cumulative Contribution | 26.7% |
Market Drivers
9/30/2025 to 4/29/2026| Return | Correlation | |
|---|---|---|
| HCSG | 26.7% | |
| Market (SPY) | 8.0% | 29.2% |
| Sector (XLI) | 10.9% | 13.2% |
Fundamental Drivers
The 111.6% change in HCSG stock from 3/31/2025 to 4/29/2026 was primarily driven by a 59.3% change in the company's Net Income Margin (%).| (LTM values as of) | 3312025 | 4292026 | Change |
|---|---|---|---|
| Stock Price ($) | 10.08 | 21.33 | 111.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,716 | 1,852 | 8.0% |
| Net Income Margin (%) | 2.3% | 3.7% | 59.3% |
| P/E Multiple | 18.8 | 21.9 | 16.9% |
| Shares Outstanding (Mil) | 74 | 70 | 5.3% |
| Cumulative Contribution | 111.6% |
Market Drivers
3/31/2025 to 4/29/2026| Return | Correlation | |
|---|---|---|
| HCSG | 111.6% | |
| Market (SPY) | 29.3% | 30.0% |
| Sector (XLI) | 31.4% | 23.6% |
Fundamental Drivers
The 53.8% change in HCSG stock from 3/31/2023 to 4/29/2026 was primarily driven by a 80.9% change in the company's Net Income Margin (%).| (LTM values as of) | 3312023 | 4292026 | Change |
|---|---|---|---|
| Stock Price ($) | 13.87 | 21.33 | 53.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,690 | 1,852 | 9.6% |
| Net Income Margin (%) | 2.0% | 3.7% | 80.9% |
| P/E Multiple | 30.1 | 21.9 | -27.1% |
| Shares Outstanding (Mil) | 74 | 70 | 6.4% |
| Cumulative Contribution | 53.8% |
Market Drivers
3/31/2023 to 4/29/2026| Return | Correlation | |
|---|---|---|
| HCSG | 53.8% | |
| Market (SPY) | 81.5% | 31.1% |
| Sector (XLI) | 75.6% | 30.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| HCSG Return | -35% | -29% | -14% | 12% | 65% | 13% | -16% |
| Peers Return | 8% | 5% | 7% | 17% | 0% | 12% | 60% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 4% | 90% |
Monthly Win Rates [3] | |||||||
| HCSG Win Rate | 50% | 50% | 50% | 42% | 58% | 50% | |
| Peers Win Rate | 54% | 52% | 56% | 65% | 48% | 75% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| HCSG Max Drawdown | -39% | -29% | -25% | -13% | -19% | -9% | |
| Peers Max Drawdown | -10% | -18% | -14% | -8% | -12% | -6% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -7% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ARMK, ABM, CTAS, UNF.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/29/2026 (YTD)
How Low Can It Go
| Event | HCSG | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -73.6% | -25.4% |
| % Gain to Breakeven | 278.4% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -42.6% | -33.9% |
| % Gain to Breakeven | 74.2% | 51.3% |
| Time to Breakeven | 298 days | 148 days |
| 2018 Correction | ||
| % Loss | -62.0% | -19.8% |
| % Gain to Breakeven | 163.3% | 24.7% |
| Time to Breakeven | Not Fully Recovered days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -48.2% | -56.8% |
| % Gain to Breakeven | 93.2% | 131.3% |
| Time to Breakeven | 809 days | 1,480 days |
Compare to ARMK, ABM, CTAS, UNF
In The Past
Healthcare Services's stock fell -73.6% during the 2022 Inflation Shock from a high on 1/27/2021. A -73.6% loss requires a 278.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Healthcare Services (HCSG)
AI Analysis | Feedback
Aramark or Sodexo for healthcare facility operations.
AI Analysis | Feedback
```html- Housekeeping Services: Cleaning, disinfecting, and sanitizing resident rooms and common areas within healthcare facilities.
- Laundry and Linen Services: Laundering and processing bed linens, uniforms, and resident personal clothing for healthcare facilities.
- Dietary Management Services: Providing food purchasing, meal preparation, professional dietitian services (including menu development), and on-site management and clinical consulting for dietary departments.
AI Analysis | Feedback
```htmlHealthcare Services Group, Inc. (HCSG) primarily sells its services to other companies and institutions. Based on the provided description, HCSG serves a broad and diversified customer base across the healthcare industry. The company does not appear to have a few dominant major customers that are explicitly named; instead, it serves approximately 3,000 facilities.
HCSG's major customers are categories of healthcare facilities, which include:
- Nursing homes
- Retirement complexes
- Rehabilitation centers
- Hospitals
Specific names of these customer companies and their public symbols are not provided in the background information.
```AI Analysis | Feedback
nullAI Analysis | Feedback
Theodore Wahl, President and Chief Executive Officer
Theodore Wahl joined Healthcare Services Group in 2004 and was appointed CEO in May 2015. He advanced through various leadership positions within the company, including Chief Operating Officer and Vice President of Finance. Prior to his tenure at HCSG, Mr. Wahl served as a Senior Manager in EY's Transaction Advisory Group.
Vikas Singh, Executive Vice President and Chief Financial Officer
Vikas Singh was appointed EVP & Chief Financial Officer in September 2024. He brings over two decades of finance experience, having most recently served as Managing Director of Leveraged Finance & Capital Markets at Bank of America Securities for 14 years. Before that, he worked in the Financial Sponsors Group at Credit Suisse for two years, where he gained expertise in financial structuring and sponsor-led transactions, indicating involvement with private equity firms. Mr. Singh began his career with GSK's Consumer Healthcare Division.
Andrew W. Kush, Executive Vice President and Chief Operating Officer
Andrew W. Kush serves as the Executive Vice President and Chief Operating Officer for Healthcare Services Group. In this role, he is responsible for overseeing and optimizing the company's daily business operations, ensuring efficient service delivery across all aspects of HCSG.
John C. Shea, Executive Vice President and Chief Administrative Officer
John C. Shea is the Executive Vice President and Chief Administrative Officer at Healthcare Services Group. He previously held the position of Chief Financial Officer for the company and has served as Vice President of Finance, Chief Accounting Officer, and Secretary. His earlier career includes roles as a Director at Pricewaterhouse Coopers (PwC) and a Senior Manager at EY.
Andrew M. Brophy, Senior Vice President, Controller and Chief Accounting Officer
Andrew M. Brophy joined Healthcare Services Group in 2018 and was promoted to Senior Vice President, Controller and Chief Accounting Officer. He has held roles of increasing responsibility within the company's accounting and finance departments, including Vice President & Controller. Mr. Brophy began his professional career in the Assurance Services practice at PwC.
AI Analysis | Feedback
Here are the key risks to Healthcare Services Group, Inc. (HCSG):
- Labor Costs and Workforce Shortages: A significant portion of Healthcare Services Group's operating expenses is attributed to labor costs, particularly within its Environmental Services segment, where it accounted for approximately 78.3% of segment revenues in 2025. The company's financial performance is highly sensitive to fluctuations in wage rates, staffing levels, and legislative changes such as minimum wage increases. The sector has struggled with workforce and occupancy levels not reaching pre-pandemic levels, leading to difficulties in hiring enough qualified personnel. This tight labor market and labor inflation continue to be a considerable headwind.
- Dependence on Healthcare Industry Dynamics, Customer Concentration, and Credit Risks: Healthcare Services Group operates exclusively within the healthcare industry, making its business susceptible to shifts in government reimbursement policies, including Medicare and Medicaid, which directly impact its clients' financial health and, consequently, HCSG's revenue streams. The company also faces customer concentration risks, highlighted by the bankruptcy of a major client (Genesis HealthCare, which represented 8.7% of 2024 consolidated revenues), demonstrating the potential for significant adverse effects from the loss of key customers or client solvency issues. Delays in payments from clients or those undergoing bankruptcy can also lead to substantial bad debts.
- Cybersecurity Risks: Healthcare Services Group is exposed to significant cybersecurity threats. In October 2024, the company experienced unauthorized activity within its systems that compromised the personal and medical details of approximately 624,500 individuals, including full names, dates of birth, Social Security numbers, financial information, and sensitive medical notes. This incident underscores the ongoing risk of data breaches and cyber-attacks, which can lead to material business impacts, potential litigation, regulatory fines, and reputational damage, despite the company's cybersecurity risk prevention programs.
AI Analysis | Feedback
NULLAI Analysis | Feedback
The addressable markets for Healthcare Services Group, Inc.'s (HCSG) main products and services in the United States are as follows:
- Dietary Services: The U.S. healthcare/hospital food services market was valued at approximately USD 22.05 billion in 2024 and is projected to reach USD 33.57 billion by 2029.
- Housekeeping Services: The U.S. healthcare environmental services market was valued at USD 6.75 billion in 2024 and is projected to reach USD 9.53 billion by 2029.
- Laundry and Linen Services: The U.S. hospital linen supply and management services market size was valued at USD 4.70 billion in 2025 and is projected to reach USD 5.12 billion in 2026.
- Facility Maintenance Services: The U.S. healthcare facilities management market, which includes facility maintenance, was estimated at USD 93 billion in 2024 and is projected to reach USD 240.9 billion by 2034.
AI Analysis | Feedback
Healthcare Services Group, Inc. (HCSG) anticipates several key drivers for future revenue growth over the next 2-3 years, as indicated by recent forward guidance and analyst commentary:
- Organic Growth through Client Expansion and Price Adjustments: The company expects accelerated organic growth in both its Environmental and Dietary Services segments, driven by an expanding client base and increases in contractual prices. New client wins and high retention rates are also contributing factors to this organic expansion.
- Strategic Mergers and Acquisitions (M&A): HCSG plans to pursue strategic M&A activities to "land and expand" in specific markets, complementing its organic growth strategy. The company actively evaluates acquisition opportunities and completed an acquisition in Q1 2025, which contributed to revenue.
- Geographic Market Expansion: Healthcare Services Group is focusing on strategic geographic expansion, with particular emphasis on developing its presence in the Midwest. This targeted expansion is expected to fuel growth over the next 12-18 months.
- Favorable Industry Demographics and Demand: The company is well-positioned to benefit from improving demand in the healthcare sector, including rising nursing home occupancy rates, which reached 85.7%. Broader demographic tailwinds, such as an aging population, are expected to drive consistent demand for outsourced non-clinical services and contribute to sustainable long-term growth.
AI Analysis | Feedback
Share Repurchases
- Healthcare Services Group completed a $50.0 million, 12-month share repurchase plan in 2025, five months ahead of schedule, with $61.6 million in total share repurchases for the year 2025.
- In February 2026, the Board of Directors authorized the repurchase of up to 10.0 million outstanding shares of common stock and announced plans to repurchase $75.0 million of its common stock over the next 12 months.
- The company repurchased over one million shares, or $11.2 million, of its common stock during 2023. Since the February 2023 share repurchase authorization, the company had repurchased approximately $23 million in common stock by Q1 2025, with 5.4 million shares remaining under that authorization. In 2024, the company repurchased over $5.0 million of its common stock.
Share Issuance
- On May 30, 2023, the company increased the authorized shares under the 2020 Omnibus Incentive Plan by 2,500,000 shares, allowing for share-based awards to officers, employees, non-employee directors, and advisors.
- In February 2026, 4,416 restricted stock units and 12,618 performance stock units (granted in February 2023) were converted into common stock, based on the achievement of financial goals through December 31, 2025.
Outbound Investments
- Healthcare Services Group made a strategic "tuck-in acquisition" in 2025, which was its first acquisition since late 2021 and was expected to contribute about 1% to 2025 revenue.
Capital Expenditures
- Capital expenditures totaled $5.4 million in 2023 and $6.3 million in 2024.
- For 2025, capital expenditures were $4.5 million for Environmental Services, $0.9 million for Dietary, and $0.4 million for Corporate Overhead, totaling approximately $5.8 million.
- The company estimated capital expenditures for 2024 to be approximately $4.0 million to $6.0 million and for 2025 to be approximately $5.0 million to $7.0 million. These expenditures primarily consist of housekeeping and food service equipment purchases, laundry and linen equipment installations, computer hardware and software, and furniture and fixtures.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| HCSG Stock (+16%): EPS Beat & Buyback Fuels Breakout | 02/12/2026 | |
| Healthcare Services Earnings Notes | 12/16/2025 | |
| Can Healthcare Services Stock Hold Up When Markets Turn? | 10/17/2025 | |
| Healthcare Services (HCSG) Operating Income Comparison | 08/08/2025 | |
| Healthcare Services (HCSG) Operating Cash Flow Comparison | 08/08/2025 | |
| Healthcare Services (HCSG) Debt Comparison | 08/08/2025 | |
| Healthcare Services (HCSG) Net Income Comparison | 08/08/2025 | |
| Healthcare Services (HCSG) Revenue Comparison | 08/08/2025 | |
| Healthcare Services (HCSG) EBITDA Comparison | 08/08/2025 | |
| Healthcare Services (HCSG) Tax Expense Comparison | 08/08/2025 | |
| ARTICLES | ||
| HCSG Stock (+16%): EPS Beat & Buyback Fuels Breakout | 02/12/2026 | |
| HCSG Stock Down -16% after 8-Day Loss Streak | 07/16/2025 |
Trade Ideas
Select ideas related to HCSG.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 03312026 | NSP | Insperity | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 03312026 | TNC | Tennant | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 03272026 | ADP | Automatic Data Processing | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 1.0% | 1.0% | 0.0% |
| 03272026 | HURN | Huron Consulting | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 4.0% | 4.0% | 0.0% |
| 03272026 | TRU | TransUnion | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 5.2% | 5.2% | 0.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 44.97 |
| Mkt Cap | 4.6 |
| Rev LTM | 8,875 |
| Op Inc LTM | 326 |
| FCF LTM | 234 |
| FCF 3Y Avg | 216 |
| CFO LTM | 403 |
| CFO 3Y Avg | 279 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 6.5% |
| Rev Chg 3Y Avg | 5.4% |
| Rev Chg Q | 6.1% |
| QoQ Delta Rev Chg LTM | 1.5% |
| Op Inc Chg LTM | 9.6% |
| Op Inc Chg 3Y Avg | 13.4% |
| Op Mgn LTM | 4.2% |
| Op Mgn 3Y Avg | 4.1% |
| QoQ Delta Op Mgn LTM | -0.0% |
| CFO/Rev LTM | 8.7% |
| CFO/Rev 3Y Avg | 5.2% |
| FCF/Rev LTM | 3.7% |
| FCF/Rev 3Y Avg | 4.7% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 4.6 |
| P/S | 0.8 |
| P/Op Inc | 22.4 |
| P/EBIT | 18.6 |
| P/E | 34.1 |
| P/CFO | 16.3 |
| Total Yield | 3.8% |
| Dividend Yield | 1.0% |
| FCF Yield 3Y Avg | 3.3% |
| D/E | 0.0 |
| Net D/E | 0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 5.0% |
| 3M Rtn | 15.0% |
| 6M Rtn | 13.4% |
| 12M Rtn | 37.7% |
| 3Y Rtn | 56.7% |
| 1M Excs Rtn | -7.5% |
| 3M Excs Rtn | 12.7% |
| 6M Excs Rtn | 8.8% |
| 12M Excs Rtn | 8.7% |
| 3Y Excs Rtn | -17.2% |
Price Behavior
| Market Price | $21.33 | |
| Market Cap ($ Bil) | 1.5 | |
| First Trading Date | 03/26/1990 | |
| Distance from 52W High | -6.8% | |
| 50 Days | 200 Days | |
| DMA Price | $20.06 | $17.87 |
| DMA Trend | up | indeterminate |
| Distance from DMA | 6.3% | 19.3% |
| 3M | 1YR | |
| Volatility | 58.9% | 44.2% |
| Downside Capture | 0.42 | 0.40 |
| Upside Capture | 114.31 | 99.78 |
| Correlation (SPY) | 28.9% | 31.7% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.56 | 1.15 | 1.17 | 1.06 | 0.82 | 0.89 |
| Up Beta | 1.67 | 0.85 | 1.73 | 1.91 | 0.92 | 0.96 |
| Down Beta | 0.80 | 3.13 | 2.05 | 1.67 | 0.57 | 0.62 |
| Up Capture | 188% | 80% | 66% | 82% | 128% | 83% |
| Bmk +ve Days | 7 | 16 | 27 | 65 | 139 | 424 |
| Stock +ve Days | 7 | 21 | 31 | 65 | 126 | 362 |
| Down Capture | 190% | 35% | 68% | 46% | 71% | 100% |
| Bmk -ve Days | 12 | 23 | 33 | 58 | 110 | 323 |
| Stock -ve Days | 15 | 21 | 32 | 60 | 122 | 371 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with HCSG | |
|---|---|---|---|---|
| HCSG | 56.7% | 44.2% | 1.14 | - |
| Sector ETF (XLI) | 33.2% | 15.2% | 1.68 | 20.4% |
| Equity (SPY) | 31.5% | 12.5% | 1.93 | 31.5% |
| Gold (GLD) | 35.2% | 27.2% | 1.09 | 3.7% |
| Commodities (DBC) | 46.7% | 18.1% | 1.99 | -5.5% |
| Real Estate (VNQ) | 12.8% | 13.4% | 0.65 | 16.9% |
| Bitcoin (BTCUSD) | -19.6% | 42.1% | -0.40 | 5.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with HCSG | |
|---|---|---|---|---|
| HCSG | -5.6% | 41.9% | -0.02 | - |
| Sector ETF (XLI) | 12.8% | 17.3% | 0.58 | 34.4% |
| Equity (SPY) | 13.1% | 17.1% | 0.60 | 34.5% |
| Gold (GLD) | 20.1% | 17.8% | 0.92 | 4.6% |
| Commodities (DBC) | 14.6% | 19.1% | 0.63 | 2.5% |
| Real Estate (VNQ) | 3.4% | 18.8% | 0.08 | 34.6% |
| Bitcoin (BTCUSD) | 8.1% | 56.2% | 0.36 | 13.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with HCSG | |
|---|---|---|---|---|
| HCSG | -3.5% | 40.4% | 0.05 | - |
| Sector ETF (XLI) | 13.6% | 19.9% | 0.60 | 39.7% |
| Equity (SPY) | 14.9% | 17.9% | 0.71 | 40.2% |
| Gold (GLD) | 13.4% | 15.9% | 0.70 | 4.1% |
| Commodities (DBC) | 9.6% | 17.7% | 0.45 | 11.0% |
| Real Estate (VNQ) | 5.5% | 20.7% | 0.23 | 38.0% |
| Bitcoin (BTCUSD) | 67.5% | 66.9% | 1.07 | 13.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 4/22/2026 | 18.3% | 11.5% | |
| 2/11/2026 | 15.8% | 5.5% | 0.9% |
| 10/22/2025 | 13.8% | 16.1% | 4.1% |
| 7/23/2025 | 12.1% | 1.7% | 16.7% |
| 4/23/2025 | 29.5% | 49.1% | 54.1% |
| 2/12/2025 | -1.8% | -2.2% | -2.2% |
| 10/23/2024 | 2.8% | 7.1% | 10.7% |
| 7/24/2024 | -6.7% | -3.0% | -9.9% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 12 | 14 |
| # Negative | 12 | 13 | 10 |
| Median Positive | 13.2% | 10.0% | 4.2% |
| Median Negative | -7.8% | -5.4% | -14.7% |
| Max Positive | 29.5% | 49.1% | 54.1% |
| Max Negative | -16.2% | -23.8% | -19.2% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 04/24/2026 | 10-Q |
| 12/31/2025 | 02/13/2026 | 10-K |
| 09/30/2025 | 10/24/2025 | 10-Q |
| 06/30/2025 | 07/25/2025 | 10-Q |
| 03/31/2025 | 04/25/2025 | 10-Q |
| 12/31/2024 | 02/14/2025 | 10-K |
| 09/30/2024 | 10/25/2024 | 10-Q |
| 06/30/2024 | 07/26/2024 | 10-Q |
| 03/31/2024 | 04/26/2024 | 10-Q |
| 12/31/2023 | 02/16/2024 | 10-K |
| 09/30/2023 | 10/27/2023 | 10-Q |
| 06/30/2023 | 07/28/2023 | 10-Q |
| 03/31/2023 | 04/28/2023 | 10-Q |
| 12/31/2022 | 02/17/2023 | 10-K |
| 09/30/2022 | 10/21/2022 | 10-Q |
| 06/30/2022 | 07/22/2022 | 10-Q |
Recent Forward Guidance [BETA]
Latest: Q1 2026 Earnings Reported 4/22/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Revenue Growth | 5.0% | 0 | 0 | Affirmed | Guidance: 5.0% for 2026 | ||
| 2026 Effective Tax Rate | 25.0% | 0 | 0 | Affirmed | Guidance: 25.0% for 2026 | ||
| 2026 Cost of Services | 0.86 | 0 | 0 | Affirmed | Guidance: 0.86 for 2026 | ||
| 2026 SG&A | 0.1 | 0.1 | 0.1 | 0 | 0 | Affirmed | Guidance: 0.1 for 2026 |
| 2027 Share Repurchases | 75.00 Mil | 0 | Same New | Guidance: 75.00 Mil for 2026 | |||
Prior: Q4 2025 Earnings Reported 2/11/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Revenue Growth | 5.0% | Higher New | |||||
| 2026 Cost of Services | 0.86 | 0 | 0 | Affirmed | Guidance: 0.86 for 2025 | ||
| 2026 SG&A | 0.1 | 0.1 | 0.1 | 0 | 0 | Affirmed | Guidance: 0.1 for 2025 |
| 2026 Effective Tax Rate | 25.0% | Higher New | |||||
| 2026 Share Repurchases | 75.00 Mil | Higher New | |||||
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Brophy, Andrew M | SVP & Chief Accounting Officer | Direct | Sell | 2262026 | 21.75 | 2,490 | 54,158 | 342,236 | Form |
| 2 | Orr, Patrick J | EVP & Chief Revenue Officer | Direct | Sell | 2192026 | 20.54 | 45,500 | 934,570 | 916,392 | Form |
| 3 | Shea, John Christopher | EVP & Chief Admin. Officer | Direct | Sell | 2192026 | 20.41 | 54,357 | 1,109,189 | 597,722 | Form |
| 4 | Shea, John Christopher | EVP & Chief Admin. Officer | Direct | Sell | 7302025 | 13.25 | 21,368 | 283,126 | 436,932 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.